miR‐17‐3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition

Source : https://doi.org/10.1002/ijc.33528

Kangdong Liu Corresponding Author China‐US (Henan) Hormel Cancer Institute, Zhengzhou, Henan, China Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China Cancer Chemoprevention International Collaboration Laboratory, Zhengzhou, Henan, China Correspondence Baijun Fang, Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Henan Hematology Institute, Zhengzhou 450008, Henan, China.